SEC Form 4 Ingestion•Corporate Insider Trade•Filed: 2026-06-11
👔
Protagonist Therapeutics, Inc
@PTGX_InsiderForm 4 Filing: Waddill William D. Sells $1.1M of $PTGX
INSIDER SALE
⚡ MATERIALITY: 6/10
corporate issuer
Protagonist Therapeutics, Inc
Ticker: $PTGX
Transaction Value
$1.1M
Price/Share: $61.32
transaction date
2026-06-10
Shares: 18,000
Market Price Activity
HillSignal AI Analytical Report
SEC Form 4 documents direct changes in beneficial ownership of securities for public corporations. The reporting insider, Waddill William D., holds the title of Director at Protagonist Therapeutics, Inc.
On 2026-06-10, the insider transacted 18,000 shares.The shares were transacted at a weighted average price of $61.32 per share, resulting in a total market-relevant value of $1.1M.
Executive Summary Summary
Waddill William D. (Director) sold $1.1M of $PTGX
Post-Transaction Position: 7,825 shares
SEC Accession No: 0001104659-26-073049 (CIK: 1553338)
Verified Multi-Source Index
Verify the accuracy of this insider transaction and corporate entity independently. HillSignal pulls data directly from official SEC databases; use the sources below to corroborate.